Q3FY17 Results : Torrent Pharmaceutcals Ltd.
Bhagyashree Vivarekar / 03 Feb 2017
Torrent Pharmaceuticals Ltd reported its results for the quarter ended December 31, 2016.The company's total sales for Q3FY17 were Rs 1443 crore, which represents a 0.98 per cent sequential increase and 6.42 per cent YoY decline.
Torrent Pharmaceuticals Ltd reported its results for the quarter ended December 31, 2016.
The company's total sales for Q3FY17 were Rs 1443 crore, which represents a 0.98 per cent sequential increase and 6.42 per cent YoY decline.
The company's operating profit (EBIT) for the quarter was Rs 243 crore and its EBIT margin was 16.84 per cent.
The company PAT was Rs 229 crore, which represents a sequential QoQ increase of 10.63 per cent and a YoY decline of 47.84 per cent.
The company's stock opened at Rs 1289 on the BSE and closed for the day at Rs.1315 mark up by 2.04 per cent.
Torrent Pharmaceuticals Ltd is an Indian pharmaceutical company having presence in cardiovascular (CV) and central nervous system (CNS), gastro-intestinal, diabetology, anti-infective and pain management segments. The company operates in one business segment, pharmaceuticals, comprising mainly manufacture of branded formulations.